Despite the availability of excellent treatment since the 1940s, Tuberculosis (TB), an ancient illness caused by the bacteria Mycobacterium tuberculosis, is nevertheless responsible for more fatalities globally each year than any other infectious disease, including the Human Immunodeficiency Virus (HIV). Antibiotic resistance is only one of the numerous obstacles in the way of putting
an end to this horrific epidemic. The disease's large geographic distribution exacerbates practical concerns such as a lack of community knowledge, access to diagnostic instruments, healthcare facilities, and patient monitoring and follow-up. Communication and coordination breakdowns between local and international control units are also a concern.
